Ascidian Therapeutics Funding: $50M Raised, Series A (2022)
Ascidian Therapeutics is based in Boston, MA. It has raised $50M in total funding. Latest round: Series A. Backed by ATP.
Ascidian Therapeutics funding overview
Ascidian Therapeutics is based in Boston, MA. Ascidian Therapeutics has raised $50M in total disclosed funding. That places its disclosed total in the $25M–$100M range. Its most recent disclosed round is a Series A announced in October 2022. The round record for Ascidian Therapeutics runs through 2022; nothing later has been disclosed. Investors on record include ATP.
Ascidian Therapeutics at a glance
Total raised
$50M
Latest round
Series A
Latest round date
October 2022
Headquarters
Boston, MA
Notable investors
ATP
Frequently asked about Ascidian Therapeutics funding
How much has Ascidian Therapeutics raised?
Ascidian Therapeutics has raised $50M in total disclosed funding across the rounds on record.
Who has invested in Ascidian Therapeutics?
ATP are named among the investors backing Ascidian Therapeutics.
What was the latest Ascidian Therapeutics funding round?
The most recent disclosed round is a Series A, announced in October 2022.
Where is Ascidian Therapeutics based?
Ascidian Therapeutics is based in Boston, MA.
When did Ascidian Therapeutics last raise?
The last disclosed Ascidian Therapeutics round closed in October 2022 at Series A.
We update the Ascidian Therapeutics record whenever a new round is filed or announced, so the totals above track the public record rather than estimates. Related companies in Boston and their backers are listed below.
